Gabapentin Use among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder

Keyphrases

• Gabapentin 100%
• Medications for Opioid Use Disorder 100%
• Buprenorphine Treatment 100%
• Drug Dependence 53%
• Poisoning 46%
• Comorbid Conditions 15%
• Non-associated 15%
• Adjusted Analysis 15%
• Non-Hispanic White 15%
• Buprenorphine 15%
• Opioid Use Disorder 15%
• Opioid Use Disorder Treatment 15%
• Hospitalization 7%
• Odds Ratio 7%
• Black Men 7%
• Safety Profile 7%
• International Classification of Diseases 7%
• Ninth Revision 7%
• Comorbid 7%
• Hispanic Patients 7%
• Disorders Diagnosis 7%
• Absence of Evidence 7%
• Mood Disorders 7%
• Hispanic 7%
• Female Patients 7%
• Crossover Design 7%
• Health Problems 7%
• Off-label Use 7%
• Neuropathic Pain 7%
• Physical Condition 7%
• Associated Risk 7%
• Medicaid Coverage 7%
• Treatment-related 7%
• Recurrent Events 7%
• Withdrawal Syndrome 7%
• Comorbid Substance Use 7%
• MarketScan 7%
• Administrative Claims Data 7%
• Tenth Revision 7%
• International Statistical Classification of Diseases 7%
• Medicaid Database 7%
• Poisoning Risk 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Gabapentin 100%
• Buprenorphine 100%
• Diseases 100%
• Toxic Injury 53%
• Combination Therapy 15%
• International Classification of Diseases 15%
• Mood Disorder 7%
• Case-Control Study 7%
• Off-Label Use 7%
• Neuropathic Pain 7%
• Withdrawal Syndrome 7%